Ritter, Ivana
Boehringer Ingelheim (Germany)
2 papers on CoChatORCID 0000-0003-1940-2440
Most cited papers
- Verified
Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial
Kraus, B. J., Weir, M. R., Bakris, G. L., Mattheus, M., Cherney, D. Z. I., Sattar, N., Heerspink, H. J. L., Ritter, I., von Eynatten, M., Zinman, B., et al. (2021) · Kidney International
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 219
- Verified
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Abraham, W. T., Lindenfeld, J., Ponikowski, P., Agostoni, P., Butler, J., Desai, A. S., Filippatos, G., Gniot, J., Fu, M., Gullestad, L., et al. (2021) · European Heart Journal
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 217
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free